The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody
Open accessAbstract
Importance: Recognizing the characteristics of myelin oligodendrocyte glycoprotein autoantibody (MOG-IgG) myelitis is essential for early accurate diagnosis and treatment. Objective: To evaluate the clinical, radiologic, and prognostic features of MOG-IgG myelitis and compare with myelitis with aquaporin-4-IgG (AQP4-IgG) and multiple sclerosis (MS). Design, Setting, and Participants: We retrospectively identified 199 MOG-IgG-positive Mayo Clinic patients from January 1, 2000, through December 31, 2017, through our neuroimmunology laboratory. Fifty-four patients met inclusion criteria of (1) clinical myelitis; (2) MOG-IgG positivity; and (3) medical records available. We excluded 145 patients without documented myelitis. Myelitis of AQP4-IgG (n = 46) and MS (n = 26) were used for comparison. Main Outcomes and Measures: Outcome variables included modified Rankin score and need for gait aid. A neuroradiologist analyzed spine magnetic resonance imaging of patients with MOG-IgG and control patients blinded to diagnosis. Results: Of 54 included patients with MOG-IgG myelitis, the median age was 25 years (range, 3-73 years) and 24 were women (44%). Isolated transverse myelitis was the initial manifestation in 29 patients (54%), and 10 (19%) were initially diagnosed as having viral/postviral acute flaccid myelitis. Cerebrospinal fluid-elevated oligoclonal bands occurred in 1 of 38 (3%). At final follow-up (median, 24 months; range, 2-120 months), 32 patients (59%) had developed 1 or more relapses of optic neuritis (n = 31); transverse myelitis (n = 7); or acute disseminated encephalomyelitis (n = 1). Clinical features favoring MOG-IgG myelitis vs AQP4-IgG or MS myelitis included prodromal symptoms and concurrent acute disseminated encephalomyelitis. Magnetic resonance imaging features favoring MOG-IgG over AQP4-IgG or MS myelitis were T2-signal abnormality confined to gray matter (sagittal line and axial H sign) and lack of enhancement. Longitudinally extensive T2 lesions were of similar frequency in MOG-IgG and AQP4-IgG myelitis (37 of 47 [79%] vs 28 of 34 [82%]; P = .52) but not found in MS. Multiple spinal cord lesions and conus involvement were more frequent with MOG-IgG than AQP4-IgG but not different from MS. Wheelchair dependence at myelitis nadir occurred in one-third of patients with MOG-IgG and AQP4-IgG but never with MS, although patients with MOG-IgG myelitis recovered better than those with AQP4-IgG. Conclusions and Relevance: Myelitis is an early manifestation of MOG-IgG-related disease and may have a clinical phenotype of acute flaccid myelitis. We identified a variety of clinical and magnetic resonance imaging features that may help clinicians identify those at risk in whom MOG-IgG should be tested.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Wingerchuk, D. M., Banwell, B., Bennett, J. L., Cabre, P., Carroll, W., Chitnis, T., de Seze, J., Fujihara, K., Greenberg, B., Jacob, A., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001729 · Cited by 4,649
Self-citationA clinical approach to diagnosis of autoimmune encephalitis
Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., Cortese, I., Dale, R. C., Gelfand, J. M., Geschwind, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00401-9 · Cited by 4,516
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288
Self-citationin cooperation with the Neuromyelitis Optica Study Group (NEMOS), Jarius, S., Ruprecht, K., Kleiter, I., Borisow, N., Asgari, N., Pitarokoili, K., Pache, F., Stich, O., Beume, L.-A., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0718-0 · Cited by 899
Consensus definitions proposed for pediatric multiple sclerosis and related disorders
Krupp, L. B., Banwell, B., & Tenembaum, S. (2007) · Neurology · doi:10.1212/01.wnl.0000259422.44235.a8 · Cited by 755
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
Jarius, S., Paul, F., Aktas, O., Asgari, N., Dale, R. C., de Seze, J., Franciotta, D., Fujihara, K., Jacob, A., Kim, H. J., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1144-2 · Cited by 747
Self-citationClinical presentation and prognosis in MOG-antibody disease: a UK study
Jurynczyk, M., Messina, S., Woodhall, M. R., Raza, N., Everett, R., Roca-Fernandez, A., Tackley, G., Hamid, S., Sheard, A., Reynolds, G., et al. (2017) · Brain · doi:10.1093/brain/awx276 · Cited by 740
Kang, S. H., Li, Y., Fukaya, M., Lorenzini, I., Cleveland, D. W., Ostrow, L. W., Rothstein, J. D., & Bergles, D. E. (2013) · Nature Neuroscience · doi:10.1038/nn.3357 · Cited by 599
Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis
Weinshenker, B. G., Wingerchuk, D. M., Vukusic, S., Linbo, L., Pittock, S. J., Lucchinetti, C. F., & Lennon, V. A. (2006) · Annals of Neurology · doi:10.1002/ana.20770 · Cited by 588
Self-citationRamanathan, S., Mohammad, S., Tantsis, E., Nguyen, T. K., Merheb, V., Fung, V. S. C., White, O. B., Broadley, S., Lechner-Scott, J., Vucic, S., et al. (2018) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316880 · Cited by 572
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
Kitley, J., Woodhall, M., Waters, P., Leite, M. I., Devenney, E., Craig, J., Palace, J., & Vincent, A. (2012) · Neurology · doi:10.1212/wnl.0b013e31826aac4e · Cited by 445
López-Chiriboga, A. S., Majed, M., Fryer, J., Dubey, D., McKeon, A., Flanagan, E. P., Jitprapaikulsan, J., Kothapalli, N., Tillema, J.-M., Chen, J., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.1814 · Cited by 410
Self-citationDobson, R., Ramagopalan, S., Davis, A., & Giovannoni, G. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304695 · Cited by 394
The spectrum of MOG autoantibody-associated demyelinating diseases
Reindl, M., Di Pauli, F., Rostásy, K., & Berger, T. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.118 · Cited by 375
Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome
Hennes, E.-M., Baumann, M., Schanda, K., Anlar, B., Bajer-Kornek, B., Blaschek, A., Brantner-Inthaler, S., Diepold, K., Eisenkölbl, A., Gotwald, T., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004312 · Cited by 341
Epidemiology of aquaporin‐4 autoimmunity and neuromyelitis optica spectrum
Flanagan, E. P., Cabre, P., Weinshenker, B. G., Sauver, J. S., Jacobson, D. J., Majed, M., Lennon, V. A., Lucchinetti, C. F., McKeon, A., Matiello, M., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24617 · Cited by 338
Self-citationMessacar, K., Schreiner, T. L., Maloney, J. A., Wallace, A., Ludke, J., Oberste, M. S., Nix, W. A., Robinson, C. C., Glodé, M. P., Abzug, M. J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62457-0 · Cited by 327
Self-citationSpinal cord infarction: clinical and magnetic resonance imaging findings and short term outcome
Masson, C. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.031724 · Cited by 284
Jurynczyk, M., Geraldes, R., Probert, F., Woodhall, M. R., Waters, P., Tackley, G., DeLuca, G., Chandratre, S., Leite, M. I., Vincent, A., et al. (2017) · Brain · doi:10.1093/brain/aww350 · Cited by 265
Short Myelitis Lesions in Aquaporin-4-IgG–Positive Neuromyelitis Optica Spectrum Disorders
Flanagan, E. P., Weinshenker, B. G., Krecke, K. N., Lennon, V. A., Lucchinetti, C. F., McKeon, A., Wingerchuk, D. M., Shuster, E. A., Jiao, Y., Horta, E. S., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2137 · Cited by 249
Self-citationUpdated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica
Jiao, Y., Fryer, J. P., Lennon, V. A., Jenkins, S. M., Quek, A. M. L., Smith, C. Y., McKeon, A., Costanzi, C., Iorio, R., Weinshenker, B. G., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a6cb5c · Cited by 244
Self-citationAcute flaccid myelitis: A clinical review of US cases 2012–2015
Messacar, K., Schreiner, T. L., Van Haren, K., Yang, M., Glaser, C. A., Tyler, K. L., & Dominguez, S. R. (2016) · Annals of Neurology · doi:10.1002/ana.24730 · Cited by 224
Self-citationDiscriminating long myelitis of neuromyelitis optica from sarcoidosis
Flanagan, E. P., Kaufmann, T. J., Krecke, K. N., Aksamit, A. J., Pittock, S. J., Keegan, B. M., Giannini, C., & Weinshenker, B. G. (2016) · Annals of Neurology · doi:10.1002/ana.24582 · Cited by 188
Self-citationLongitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases
Hyun, J., Woodhall, M. R., Kim, S., Jeong, I. H., Kong, B. S., Kim, G., Kim, Y., Park, M. S., Irani, S. R., Waters, P. J., et al. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-315998 · Cited by 156
MOG antibody-related disorders: common features and uncommon presentations
Cobo‐Calvo, Á., Ruiz, A., d’Indy, H., Poulat, A., Carneiro, M., Nicolas, P., Durand‐Dubief, F., Deiva, K., Vukusic, S., Portes, V. D., et al. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8583-z · Cited by 137
Jitprapaikulsan, J., Chen, J. J.-W., Flanagan, E. P., Tobin, W. O., Fryer, J., Weinshenker, B. G., McKeon, A. B., Lennon, V. A., Leavitt, J. A., Tillema, J., et al. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2018.03.041 · Cited by 130
Self-citationEvaluation of idiopathic transverse myelitis revealing specific myelopathy diagnoses
Zalewski, N. L., Flanagan, E. P., & Keegan, B. M. (2017) · Neurology · doi:10.1212/wnl.0000000000004796 · Cited by 114
Self-citationBannerman, P. G. C., Hahn, A., Ramirez, S., Morley, M. P., Bönnemann, C. G., Yu, S., Zhang, G.-X., Rostami, A. M., & Pleasure, D. (2005) · Brain · doi:10.1093/brain/awh550 · Cited by 103
Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders
Zalewski, N. L., Morris, P. P., Weinshenker, B. G., Lucchinetti, C. F., Guo, Y. X., Pittock, S. J., Krecke, K. N., Kaufmann, T. J., Wingerchuk, D. M., Kumar, N., et al. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-314738 · Cited by 83
Self-citationOutcomes of Colorado children with acute flaccid myelitis at 1 year
Martin, J. A., Messacar, K., Yang, M. L., Maloney, J. A., Lindwall, J. J., Carry, T., Kenyon, P., Sillau, S., Oleszek, J. L., Tyler, K. L., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004081 · Cited by 82
Self-citationMills, J. D., Kavanagh, T., Kim, W. S., Chen, B. J., Kawahara, Y., Halliday, G. M., & Janitz, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078480 · Cited by 50
Bouzar, M., Daoudi, S., Hattab, S., Bouzar, A. A., Deiva, K., Wildemann, B., Reindl, M., & Jarius, S. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.08.3254 · Cited by 33
Treatment of Acute Transverse Myelitis and Its Early Complications
Greenberg, B. M. (2011) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000403792.36161.f5 · Cited by 19
The gray aspects of white matter disease in multiple sclerosis
Steinman, L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903377106 · Cited by 18
Cited by
Banwell, B., Bennett, J. L., Marignier, R., Kim, H. J., Brilot, F., Flanagan, E. P., Ramanathan, S., Waters, P., Tenembaum, S., Graves, J. S., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00431-8 · Cited by 1,246
Self-citationWattjes, M. P., Ciccarelli, O., Reich, D. S., Banwell, B., de Stefano, N., Enzinger, C., Fazekas, F., Filippi, M., Frederiksen, J., Gasperini, C., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00095-8 · Cited by 674
Myelin oligodendrocyte glycoprotein antibodies in neurological disease
Reindl, M., & Waters, P. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0112-x · Cited by 626
Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines
Filippi, M., Preziosa, P., Banwell, B. L., Barkhof, F., Ciccarelli, O., De Stefano, N., Geurts, J. J. G., Paul, F., Reich, D. S., Toosy, A. T., et al. (2019) · Brain · doi:10.1093/brain/awz144 · Cited by 560
Self-citationMyelin-oligodendrocyte glycoprotein antibody-associated disease
Marignier, R., Hacohen, Y., Cobo-Calvo, A., Pröbstel, A.-K., Aktas, O., Alexopoulos, H., Amato, M.-P., Asgari, N., Banwell, B., Bennett, J., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00218-0 · Cited by 543
Self-citation
Metadata
- Authors
- Dubey, D., Pittock, S. J., Krecke, K. N., Morris, P. P., Sechi, E., Zalewski, N. L., Weinshenker, B. G., Shosha, E., Lucchinetti, C. F., Fryer, J. P., Lopez-Chiriboga, A. S., Chen, J. C., Jitprapaikulsan, J., McKeon, A., Gadoth, A., Keegan, B. M., Tillema, J.-M., Naddaf, E., Patterson, M. C., Messacar, K., Tyler, K. L., & Flanagan, E. P.
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2019-03-01
- Volume
- 76
- Issue
- 3
- Pages
- 301
- ISSN
- 2168-6149 (ISSN-L)
- OpenAlex
- W2905801855
- Cited by
- 384
- References
- 34
- FWCI
- 22.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.